August 8, 2012
Editor's Note: We had opportunities to catch up with so many great partners while at the XIX International Conference on AIDS (AIDS 2012) in July, we are continuing to bring you interviews on a host of important issues.
During the XIX International AIDS Conference (AIDS 2012) last month, I had an opportunity to catch up with Dr. Gina Brown, Coordinator of Women and Girls and Microbicides Research at the NIH's Office of AIDS Research. We discussed interesting information presented at AIDS 2012 about HIV prevention, care, and treatment for women and girls, as well as related research supported by NIH. The topics we talked about included the exploration of whether hormonal contraceptives potentially increase HIV risk for women using them; the latest developments in microbicide research, including NIH's announcement of the ASPIRE study, a study to evaluate a vaginal ring that contains an antiretroviral drug originally developed to treat HIV; the ongoing long-term study of women and HIV (Women's Interagency HIV Study or WIHS); the Women's HIV SeroIncidence Study (ISIS); and the intersection of and need to further examine domestic/intimate partner violence and HIV among women. Watch our brief conversation below.
Stay tuned for more posts featuring conversations from AIDS 2012 later this week and next.
Ronald Valdiserri, M.D., M.P.H. is deputy assistant secretary for health, infectious diseases, and director of the Office of HIV/AIDS and Infectious Disease Policy at the U.S. Department of Health and Human Services.
No comments have been made.
|Please note: Knowledge about HIV changes rapidly. Note the date of this summary's publication, and before treating patients or employing any therapies described in these materials, verify all information independently. If you are a patient, please consult a doctor or other medical professional before acting on any of the information presented in this summary. For a complete listing of our most recent conference coverage, click here.|